Sandra Lord

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes”.

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

JCI Insight(2021)10.1172/jci.insight.150074

N/A

2.2DataRank · unranked

59 citations

Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord +31 more

SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

Nature Communications(2023)10.1038/s41467-023-36686-8

N/A

1.7DataRank · unranked

46 citations

Carolina Lucas, İnci Yıldırım, Yile Dai, Eric Y. Wang, Valter Silva Monteiro +13 more

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

Diabetes Care(2023)10.2337/dc22-2200

N/A

0.691DataRank · unranked

99 citations

Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland +21 more

Hydroxychloroquine in Stage 1 Type 1 Diabetes

Diabetes Care(2023)10.2337/dc23-1096

N/A

0.622DataRank · unranked

17 citations

Polly J. Bingley, Dorothy J. Becker, Jane H. Buckner, Linda A. DiMeglio, Stephen E. Gitelman +58 more

OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody–Positive Individuals

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad472

N/A

0.550DataRank · unranked

38 citations

Cate Speake, Susan L. Pietropaolo, Darrell M. Wilson, Andrea K. Steck, Jennifer L. Sherr +5 more

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes

PLoS Pathogens(2022)10.1371/journal.ppat.1010592

N/A

0.510DataRank · unranked

29 citations

Rachel Eguia, Tyler N. Starr, Khadija Khan, Nicholas Franko, Jennifer K. Logue +6 more

Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes Diagnosis

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac594

N/A

0.360DataRank · unranked

10 citations

Alyssa Ylescupidez, Henry T. Bahnson, Christine Bender, Cate Speake, Sandra Lord +2 more

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial

JCI Insight(2025)10.1172/jci.insight.191266

N/A

0.104DataRank · unranked

1 citations

Catriona A. Wagner, Ashley Pinckney, Jeffrey A. Cohen, Zachary S. Wallace, Arezou Khosroshahi +36 more

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

Nature Communications(2023)10.1038/s41467-023-42581-z

N/A

0DataRank · unranked

22 citations

Henry T. Bahnson, Colin O’Rourke, Sandra Lord, Cate Speake, Carla J. Greenbaum +1 more

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.12.484088

N/A

0DataRank · unranked

7 citations

Rachel Eguia, Tyler N. Starr, Khadija Khan, Nicholas Franko, Jennifer K. Logue +6 more

Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials

Journal of the Endocrine Society(2023)10.1210/jendso/bvad003

N/A

0DataRank · unranked

6 citations

Lu You, Emily K. Sims, Diane K. Wherrett, Desmond Schatz, Sandra Lord +9 more

Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae292

N/A

0DataRank · unranked

9 citations

Colin O’Rourke, Alyssa Ylescupidez, Megan E. Smithmyer, Christine Bender, Cate Speake +3 more

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

JCI Insight(2022)10.1172/jci.insight.159436

N/A

0DataRank · unranked

21 citations

Tania Habib, Katharina Lambert, Christian Hundhausen, Sandra Lord, Matthew J. Dufort +11 more